VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PBYI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PBYIPuma Biotechnology, Inc.
$7.96$405M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPBYIQuarterly Financials

Puma Biotechnology, Inc. (PBYI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Puma Biotechnology, Inc. (PBYI) quarterly income statement — complete revenue, gross profit & net income history

PBYI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue44.81M75.45M54.48M52.44M46.01M59.08M80.54M47.08M43.77M72.18M56.12M54.57M52.77M65.67M57.1M59.52M45.74M55.36M46.24M53.38M
Revenue Growth %-2.59%27.72%-32.36%11.37%5.12%-18.15%43.53%-13.72%-17.07%9.9%-1.73%-8.32%15.39%18.64%23.48%11.49%-53.41%5.33%-8.88%-24.37%
Cost of Goods Sold10.42M23.13M12.17M12.3M10.56M13.92M29.1M10.66M10.73M24.32M13.28M11.86M13.22M16.84M12.49M14.92M10.84M11.89M10.28M11.97M
COGS % of Revenue23.26%30.65%22.35%23.46%22.94%23.56%36.13%22.64%24.51%33.7%23.67%21.73%25.05%25.64%21.88%25.06%23.71%21.49%22.23%22.42%
Gross Profit34.39M52.33M42.3M40.13M35.45M45.16M51.45M36.42M33.04M47.85M42.83M42.71M39.56M48.84M44.61M44.6M34.89M43.46M35.97M41.41M
Gross Margin %76.74%69.35%77.65%76.54%77.06%76.44%63.87%77.36%75.49%66.3%76.33%78.27%74.95%74.36%78.12%74.94%76.29%78.51%77.77%77.58%
Gross Profit Growth %-2.99%15.88%-17.77%10.19%7.3%-5.64%20.11%-14.72%-16.48%-2.01%-3.98%-4.24%13.37%12.37%24.03%7.69%-49.15%4.43%-11.87%-32.29%
Operating Expenses38.22M35.22M32.73M33.5M31.47M31.79M29.37M38.6M35.34M33.06M34.25M37.82M35.19M38.82M42.21M32.54M35.64M67.05M44.92M58.05M
OpEx % of Revenue85.28%46.68%60.08%63.89%68.4%53.81%36.46%81.99%80.74%45.8%61.03%69.31%66.68%59.11%73.93%54.68%77.92%121.12%97.13%108.74%
Selling, General & Admin18.42M18.38M17.03M18.41M17.39M17.02M16.87M24.97M21.75M20.18M22.18M23.95M22.49M25.04M23.96M20.58M20.4M22.46M26.08M39.41M
SG&A % of Revenue41.11%24.36%31.26%35.11%37.8%28.81%20.94%53.04%49.7%27.96%39.52%43.89%42.61%38.13%41.96%34.57%44.61%40.58%56.4%73.82%
Research & Development19.8M16.84M15.91M15.45M13.86M15.17M12.55M13.63M13.59M12.87M11.45M13.36M12.71M13.78M11.25M11.97M15.24M14.17M18.84M18.64M
R&D % of Revenue44.17%22.32%29.21%29.47%30.13%25.68%15.58%28.95%31.04%17.84%20.4%24.48%24.08%20.99%19.71%20.1%33.32%25.59%40.73%34.91%
Other Operating Expenses00-213K-362K213K-398K-48K000625K514K001000K001000K00
Operating Income-3.83M17.11M9.57M6.64M3.98M13.37M22.08M-2.18M-2.3M14.8M8.59M4.89M4.37M10.02M2.39M12.06M-747K-23.58M-8.95M-16.63M
Operating Margin %-8.54%22.67%17.57%12.66%8.66%22.62%27.41%-4.63%-5.25%20.5%15.3%8.96%8.27%15.25%4.19%20.26%-1.63%-42.6%-19.36%-31.16%
Operating Income Growth %-196.08%27.99%-56.64%404.54%273.29%-9.68%157.18%-144.54%-152.67%47.74%258.75%-59.43%684.34%142.47%126.73%172.49%-103.71%-111.53%26.19%-333.31%
EBITDA-1.33M19.76M12.29M9.4M6.78M16.21M24.96M729K598K17.69M11.46M7.77M7.24M12.22M4.86M14.52M1.71M-21.31M-6.51M-13.7M
EBITDA Margin %-2.96%26.19%22.57%17.92%14.74%27.43%30.99%1.55%1.37%24.5%20.42%14.24%13.72%18.61%8.51%24.39%3.74%-38.5%-14.08%-25.66%
EBITDA Growth %-119.59%21.95%-50.74%1189.3%1033.78%-8.37%117.76%-90.62%-91.74%44.7%135.73%-46.5%323.57%157.35%174.65%205.99%-92.6%-159.88%29.2%-246.25%
D&A (Non-Cash Add-back)2.5M2.66M2.72M2.76M2.8M2.84M2.88M2.91M2.9M2.89M2.88M2.88M2.88M2.21M2.47M2.46M2.46M2.27M2.44M2.94M
EBIT-3.83M18.23M10.73M8M5.44M14.86M23.71M-779K-1.24M15.42M8.59M5.64M4.86M-2.03M2.65M12.13M-702K7.15M-41.51M-1.55M
Net Interest Income271K-142K-445K-881K-1.08M-1.4M-1.82M-2.13M-2.39M-2.63M-2.65M-2.67M-2.77M-2.76M-2.73M-2.64M-2.65M-2.71M-3.11M-3.4M
Interest Income1M977K1.04M956K1.1M1.23M1.28M1.24M972K719K689K660K537K519K216K65K13K13K13K121K
Interest Expense731K1.12M1.49M1.84M2.18M2.62M3.1M3.37M3.36M3.35M3.34M3.33M3.31M3.28M2.95M2.7M2.66M2.72M3.12M3.52M
Other Income/Expense401K1K-330K-471K-717K-1.13M-1.47M-1.97M-2.3M-1.99M-2.58M-2.58M-2.82M-15.33M-2.69M-2.63M-2.62M28.02M-35.68M11.56M
Pretax Income-3.43M17.11M9.24M6.17M3.27M12.24M20.61M-4.15M-4.59M12.8M6.01M2.31M1.55M-5.31M-293K9.43M-3.37M4.44M-44.63M-5.07M
Pretax Margin %-7.65%22.67%16.97%11.76%7.1%20.72%25.59%-8.82%-10.5%17.74%10.71%4.24%2.93%-8.09%-0.51%15.84%-7.36%8.01%-96.52%-9.49%
Income Tax326K3.67M399K310K293K-7.07M291K378K220K536K213K187K147K294K67K57K37K212K37K38K
Effective Tax Rate %-9.51%21.45%4.32%5.03%8.97%-57.75%1.41%-9.11%-4.79%4.19%3.54%8.08%9.5%-5.53%-22.87%0.6%-1.1%4.78%-0.08%-0.75%
Net Income-3.75M13.44M8.84M5.86M2.97M19.3M20.32M-4.53M-4.82M12.27M5.8M2.13M1.4M-5.61M-360K9.37M-3.4M4.22M-44.67M-5.11M
Net Margin %-8.37%17.81%16.23%11.17%6.46%32.68%25.23%-9.62%-11%17%10.33%3.9%2.65%-8.54%-0.63%15.74%-7.44%7.63%-96.6%-9.56%
Net Income Growth %-226.19%-30.39%-56.47%229.28%161.77%57.36%250.53%-313.03%-443.68%318.84%1710%-77.31%141.17%-232.72%99.19%283.53%-120.59%128.17%-41.98%-250.4%
Net Income (Continuing)-3.75M13.44M8.84M5.86M2.97M19.3M20.32M-4.53M-4.82M12.27M5.8M2.13M1.4M-5.61M-360K9.37M-3.4M4.22M-44.67M-5.11M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.070.260.170.120.060.390.41-0.09-0.100.260.120.050.03-0.12-0.010.21-0.080.10-1.09-0.13
EPS Growth %-223.83%-33.33%-58.54%227.93%159.66%50%241.67%-308.44%-436.36%316.67%--78.57%136.85%-220%99.28%261.54%-120.15%126.32%-37.97%-262.5%
EPS (Basic)-0.070.270.180.120.060.390.41-0.09-0.100.260.120.050.03-0.12-0.010.21-0.080.10-1.09-0.13
Diluted Shares Outstanding50.85M51.52M50.93M50.14M49.91M49.41M49.17M48.29M48.19M48.04M47.82M47.2M47.16M45.81M45.57M45.36M42.21M41.04M40.81M40.48M
Basic Shares Outstanding50.85M50.34M50.34M49.7M49.6M49.1M49.01M48.29M48.19M47.6M47.52M46.76M46.64M45.81M45.57M45.06M42.21M40.99M40.81M39.28M
Dividend Payout Ratio--------------------